Omega-3 Breakthrough for Kidney Patients as Study Links Higher Levels to Better Heart and Kidney Survival
Nikhil Prasad Fact checked by:Thailand Medical News Team Jun 01, 2026 1 hour, 2 minutes ago
Medical News: A new long-term study is offering fresh hope for millions of people living with chronic kidney disease (CKD), revealing that higher levels of omega-3 fatty acids in the blood may significantly reduce the risk of serious cardiovascular complications, kidney failure, and death.
Higher blood levels of omega-3 fatty acids were linked to fewer heart complications, slower kidney disease
progression, and improved long-term survival in chronic kidney disease patients
Researchers from the Department of Nephrology, Transplantology and Internal Medicine at the Medical University of Gdansk, the Department of Pharmaceutical Biochemistry at the Medical University of Gdansk, the Department of Environmental Analytics at the University of Gdansk, and the Department of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine at the Medical University of Gdansk in Poland tracked patients with chronic kidney disease for an entire decade. Their findings suggest that maintaining healthier levels of omega-3 fatty acids could play an important role in improving long-term outcomes for this vulnerable population.
Why Chronic Kidney Disease Patients Face Higher Risks
Chronic kidney disease affects hundreds of millions of people worldwide and is known to dramatically increase the risk of cardiovascular disease. In fact, heart attacks and strokes remain the leading causes of death among individuals with kidney disease.
Scientists have long suspected that changes in blood fat composition may contribute to these risks. Of particular interest are polyunsaturated fatty acids, commonly known as omega-3 and omega-6 fats. Omega-3 fats, especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are typically found in fish and fish oils and are known for their anti-inflammatory and heart-protective effects.
Previous research had shown that patients with chronic kidney disease often have lower levels of beneficial omega-3 fats. However, it remained unclear whether these reduced levels could predict future health outcomes.
Ten-Year Follow-Up Reveals Striking Differences
The study followed 77 patients with chronic kidney disease whose blood fatty acid profiles had been measured approximately ten years earlier. Researchers then examined how many experienced major adverse events including kidney failure requiring dialysis, heart attack, stroke, or death.
During the decade-long follow-up period, 23 patients progressed to kidney failure requiring renal replacement therapy, nine suffered heart attacks, six experienced strokes, and five died. Overall, 34 participants reached at least one of these serious outcomes.
The most notable finding was that patients who experienced these adverse events had significantly lower levels of omega-3 fatty acids at the beginning of the study compared to those who remained free from major complications.
Statistical analysis showed that higher omega-3 levels were associated with a substantially lower risk of reaching the combined endpoint of kidney failure, cardiovascular events, or death. Even after adjusting for facto
rs such as age, diabetes, and kidney function, the protective relationship remained significant.
The Importance of the Omega-3 to Omega-6 Balance
Researchers discovered that not only the amount of omega-3 fats mattered, but also the balance between omega-3 and omega-6 fatty acids.
Patients with a higher omega-3-to-omega-6 ratio experienced better event-free survival throughout the ten-year follow-up. This finding is important because omega-3 and omega-6 fats compete within the body to produce signaling molecules that influence inflammation and blood clotting.
A higher proportion of omega-3 fats generally promotes anti-inflammatory effects, while excessive omega-6 levels may favor processes linked to inflammation and vascular damage.
This
Medical News report highlights that patients who suffered heart attacks or strokes had significantly higher omega-6 levels and lower omega-3-to-omega-6 ratios than those who avoided such events.
EPA Emerges as a Key Marker for Kidney Protection
One of the most intriguing findings involved EPA, a major omega-3 fatty acid commonly found in oily fish.
Patients who eventually required dialysis or other forms of renal replacement therapy had markedly lower EPA levels at the start of the study. Although some additional analyses reduced the statistical strength of this association, the overall trend consistently suggested that higher EPA levels may help protect kidney function over time.
The researchers noted that omega-3 fats may provide benefits through several mechanisms, including reducing inflammation, lowering triglycerides, improving blood vessel function, decreasing oxidative stress, and helping regulate blood pressure.
Dietary Intake Alone Did Not Predict Outcomes
Interestingly, when researchers examined dietary questionnaires completed at the beginning of the study, they found no clear link between reported consumption of fish, nuts, or seeds and long-term outcomes.
The team cautioned that dietary surveys may not accurately reflect actual long-term eating habits and that blood fatty acid measurements may provide a more reliable picture of a person's biological exposure to beneficial fats.
Conclusion
The findings add to growing evidence that omega-3 fatty acids may play a meaningful role in protecting both the heart and kidneys in people with chronic kidney disease. Patients with higher blood levels of omega-3 fats, particularly those maintaining a healthier balance between omega-3 and omega-6 fatty acids, experienced fewer serious complications over a ten-year period. While the study was relatively small and cannot prove cause and effect, its exceptionally long follow-up strengthens the significance of the observations. The researchers stress that larger clinical studies are still needed to determine whether actively improving omega-3 status through diet or supplementation can directly reduce the risks of kidney failure, heart attacks, strokes, and death. Nevertheless, the findings suggest that blood fatty acid profiles may become an important tool for identifying CKD patients at higher risk and potentially guiding future preventive strategies.
The study findings were published in the peer reviewed journal: Nutrients.
https://www.mdpi.com/2072-6643/18/11/1760
For the latest on omega supplements and chronic kidney disease, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/nephrology-(kidneys)
https://www.thailandmedical.news/articles/supplements
Share
Tweet
Share
